Hepatitis B Vaccination in HIV-Infected Youth: A Randomized Trial of Three Regimens

被引:41
|
作者
Flynn, Patricia M. [1 ,2 ,3 ]
Cunningham, Coleen K. [4 ]
Rudy, Bret [5 ]
Wilson, Craig M. [6 ]
Kapogiannis, Bill [7 ]
Worrell, Carol [7 ]
Bethel, James [8 ]
Monte, Dina [8 ]
Bojan, Kelly [9 ]
机构
[1] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA
[3] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA
[4] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA
[5] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA
[6] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA
[7] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Pediat Adolescent & Maternal AIDS Branch, NIH, Rockville, MD USA
[8] Westat Corp, Rockville, MD USA
[9] Core Ctr, Adolescent Div, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
HIV; hepatitis B vaccination; adolescents; Engerix B; Twinrix; IMPAIRED RESPONSE; SEROLOGIC RESPONSE; ANTIBODY-RESPONSE; HOMOSEXUAL MEN; A VACCINE; CHILDREN; IMMUNIZATION; EFFICACY; INFANTS; IMMUNOGENICITY;
D O I
10.1097/QAI.0b013e318203e9f2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: HIV-infected youth are at risk of hepatitis B infection and should be vaccinated. Previous reports suggest reduced response to standard hepatitis B vaccine regimens. Methods: HIV-infected youth, aged 12 to younger than 25 years, were randomly assigned to one of three treatment arms: Arm 1: Engerix B, 20 mg HBsAg; Arm 2: Engerix B (GlaxoSmithKline, Rixensart, Belgium), 40 mg; and Arm 3: Twinrix (GlaxoSmithKline, Rixensart, Belgium), 20 mg HBsAg combined with 720 ELU hepatitis A antigen. Vaccines were administered at Weeks 0, 4, and 24. Results: Characteristics of evaluable patients (n = 336) at entry were similar in the study arms. At enrollment, median CD4(+) T-cell count was 460 cells/mm(3) (interquartile range, 305-668); 13% were less than 200 cells/mm(3). Among Engerix B, 20-mg recipients, 60.4% responded to vaccine (HBsAb 10 IU/mL or greater at Week 28). Improved vaccine response was seen in recipients of Engerix B, 40 mg (73.2% versus Arm 1, P = 0.04) and Twinrix (75.4% versus Arm 1, P = 0.02). In multivariate analysis, only baseline CD4(+) T-cell count and study arm were independent predictors of vaccine response. Conclusions: In HIV-infected youth, a three-dose vaccination regimen with Engerix B, 40 mg, or Twinrix and higher baseline CD4(+) T-cell counts were independently associated with improved vaccine response.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [21] Occult hepatitis B in HIV-infected patients
    Shire, NJ
    Rouster, SD
    Rajicic, N
    Sherman, KE
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (03) : 869 - 875
  • [22] Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
    Kim, H. Nina
    Harrington, Robert D.
    Van Rompaey, Stephen E.
    Kitahata, Mari M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2008, 19 (09) : 600 - 604
  • [23] Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice
    Mena, Guillermo
    Llupia, Anna
    Garcia-Basteiro, Alberto L.
    Diez, Consolacion
    Leon, Agathe
    Garcia, Felipe
    Bayas, Jose M.
    VACCINE, 2012, 30 (24) : 3703 - 3709
  • [24] Hepatitis B coinfection in HIV-infected patients
    Gabriela Jugănariu
    Cristina Nicolau
    Liviu Jany Prisăcariu
    Carmen Manciuc
    Andra Teodor
    Cătălina Luca
    Carmen Dorobăț
    BMC Infectious Diseases, 13 (Suppl 1)
  • [25] Double dose versus standard dose hepatitis B vaccine in HIV-infected children: A randomized controlled trial
    Shahid Akhtar Siddiqui
    Manisha Maurya
    Dk Singh
    Anubha Srivastava
    Ruchi Rai
    Indian Pediatrics, 2017, 54 : 1017 - 1020
  • [26] Hepatitis B screening in HIV-infected individuals
    Fowler, A
    Sudhanva, M
    Zuckerman, M
    AIDS, 2005, 19 (12) : 1338 - 1339
  • [27] Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial
    Prachi Jain
    Pooja Dewan
    Sunil Gomber
    Bineeta Kashyap
    Alpana Raizada
    Indian Pediatrics, 2021, 58 : 224 - 228
  • [28] Three vs Four Dose Schedule of Double Strength Recombinant Hepatitis-B Vaccine in HIV-infected Children: A Randomized Controlled Trial
    Jain, Prachi
    Dewan, Pooja
    Gomber, Sunil
    Kashyap, Bineeta
    Raizada, Alpana
    INDIAN PEDIATRICS, 2021, 58 (03) : 224 - 228
  • [29] Serologic Response to Hepatitis B Vaccination in HIV-Infected Patients with Isolated Positivity for Antibodies to Hepatitis B Core Antigen
    Chakvetadze, Catherine
    Bani-Sadr, Firouze
    Le Pendeven, Catherine
    Lescure, Francois-Xavier
    Fontaine, Camille
    Galperine, Tatiana
    Slama, Laurence
    Bonnard, Philippe
    Mariot, Philippe
    Soussan, Patrick
    Pialoux, Gilles
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (08) : 1184 - 1186
  • [30] Immune response to hepatitis A vaccination in HIV-infected men in Greece
    Kourkounti, S.
    Mavrianou, N.
    Paparizos, Va
    Kyriakis, K.
    Hatzivassiliou, M.
    Kordosis, T.
    Katsambas, A.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (07) : 464 - 467